News Details
12 January 2015

Canadian Institutes of Health Award

A Kosterlitz project for the treatment of neuropathic and inflammatory pain has received an award of from the Canadian Institutes of Health Proof of Principle Phase II scheme and Signal Pharma.

Congratulations to Professor Ruth Ross and Dr Iain Greig, recipients of a total award of $489,000 from the Canadian Institutes of Health and Signal Pharma.  Ross and Greig are developing cannabinoid receptor type 1 (CB1) allosteric enhancers for the treatment of different types of pain, for which existing treatments (opiates and NSAIDs) are generally ineffective.


back



In This Section

Search News

Search News

Browse by Month

2015

2015

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec

2014

2013